Jeroen Bakker

Jeroen Bakker is an experienced investor and board member in the biotechnology and life sciences sectors. Currently, Jeroen holds investment roles at Phasecraft and Sparrow Quantum as well as a partner position at Novo Holdings, where Jeroen focuses on early-stage investments in innovative scientific startups aimed at transforming patient treatment. Jeroen's board memberships include Commit Biologics, Adcendo, Rappta Therapeutics, Antag Therapeutics, BiOrigin, and ISD Immunotech. Jeroen has also served as Interim Chief Business Officer and Interim Chief Operations Officer at Inthera Bioscience. Jeroen's educational background includes a PhD in Immunology from the University of Amsterdam and advanced programs at notable institutions such as IMD and London Business School.